{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:58:04Z","timestamp":1793051884307,"version":"4.5.0"},"reference-count":185,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Celagenex Research, Mumbai, India","award":["Grant Number: ISFAL\/24-25\/344"],"award-info":[{"award-number":["Grant Number: ISFAL\/24-25\/344"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-61362-4","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:12:05Z","timestamp":1783595525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multitarget therapeutic potential of sulforaphane in ethidium bromide-induced neurotoxicity in multiple sclerosis-like pathology: comparison with omaveloxolone and dimethyl fumarate on neuroprotection and systemic recovery"],"prefix":"10.1038","volume":"16","author":[{"given":"Divya","family":"Choudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0034-835X","authenticated-orcid":false,"given":"Sidharth","family":"Mehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritam","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MD Nasiruddin","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanshyam Das","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajaram","family":"Samant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Tongra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"61362_CR1","doi-asserted-by":"publisher","first-page":"177417","DOI":"10.1016\/j.ejphar.2025.177417","volume":"995","author":"D Choudhary","year":"2025","unstructured":"Choudhary, D. et al. Navigating the complexities of neuronal signaling and targets in neurological disorders: From pathology to therapeutics. Eur. J. Pharmacol. 995, 177417. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177417 (2025).","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"61362_CR2","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.cell.2025.10.034","volume":"189","author":"JL Wang","year":"2026","unstructured":"Wang, J. L. et al. Elucidating pathway-selective biased CCKBR agonism for Alzheimer\u2019s disease treatment. Cell 189(2), 640\u2013658. https:\/\/doi.org\/10.1016\/j.cell.2025.10.034 (2026).","journal-title":"Cell"},{"issue":"14","key":"61362_CR3","doi-asserted-by":"publisher","first-page":"7965","DOI":"10.1021\/acs.inorgchem.6c00360","volume":"65","author":"LC Meng","year":"2026","unstructured":"Meng, L. C. et al. Schiff Base-Wrapped Co, Zn-Based Clusters with Hierarchical Chiral Structures for Therapeutic Application in Parkinson\u2019s Disease. Inorg Chem. 65(14), 7965\u20137973. https:\/\/doi.org\/10.1021\/acs.inorgchem.6c00360 (2026).","journal-title":"Inorg Chem."},{"key":"61362_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-00448-7","author":"M D\u2019Souza","year":"2021","unstructured":"D\u2019Souza, M., Papadopoulou, A., Girardey, C. & Kappos, L. Standardization and digitization of clinical data in multiple sclerosis. Nat. Rev. Neurol. https:\/\/doi.org\/10.1038\/s41582-020-00448-7 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"61362_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/glia.24235","author":"J Steudler","year":"2022","unstructured":"Steudler, J. et al. Autoimmune neuroinflammation triggers mitochondrial oxidation in oligodendrocytes. Glia https:\/\/doi.org\/10.1002\/glia.24235 (2022).","journal-title":"Glia"},{"key":"61362_CR6","doi-asserted-by":"crossref","unstructured":"Pi\u00f1ar-morales, R., Dur\u00e1n, R., Bautista-garc\u00eda, A., Garc\u00eda-mansilla, M. J., Aliaga-gaspar, P., Vives-montero, F., et al. The impact of oxidative stress on symptoms associated with multiple sclerosis. pp. 1\u201312. (2025).","DOI":"10.1038\/s41598-025-07429-0"},{"key":"61362_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.187","author":"T Olsson","year":"2016","unstructured":"Olsson, T., Barcellos, L. F. & Alfredsson, L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat. Rev. Neurol. https:\/\/doi.org\/10.1038\/nrneurol.2016.187 (2016).","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"61362_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi, M. et al. Multiple sclerosis. Nat. Rev. Dis. Prim. 4(1), 1\u201327. https:\/\/doi.org\/10.1038\/s41572-018-0041-4 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"61362_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2023.1207007","author":"D Packer","year":"2023","unstructured":"Packer, D., Fresenko, E. E. & Harrington, E. P. Remyelination in animal models of multiple sclerosis: Finding the elusive grail of regeneration. Front. Mol. Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2023.1207007 (2023).","journal-title":"Front. Mol. Neurosci."},{"key":"61362_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-021-00691-x","author":"N Kumar","year":"2021","unstructured":"Kumar, N., Sharma, N., Khera, R., Gupta, R. & Mehan, S. Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological alterations in rat brain. Metab. Brain Dis. https:\/\/doi.org\/10.1007\/s11011-021-00691-x (2021).","journal-title":"Metab. Brain Dis."},{"key":"61362_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2013.02.014","author":"NJ Kuypers","year":"2013","unstructured":"Kuypers, N. J., James, K. T., Enzmann, G. U., Magnuson, D. S. K. & Whittemore, S. R. Functional consequences of ethidium bromide demyelination of the mouse ventral spinal cord. Exp. Neurol. https:\/\/doi.org\/10.1016\/j.expneurol.2013.02.014 (2013).","journal-title":"Exp. Neurol."},{"key":"61362_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-023-01214-6","author":"S Chhabra","year":"2023","unstructured":"Chhabra, S. & Mehan, S. Matrine exerts its neuroprotective effects by modulating multiple neuronal pathways. Metab. Brain Dis. https:\/\/doi.org\/10.1007\/s11011-023-01214-6 (2023).","journal-title":"Metab. Brain Dis."},{"key":"61362_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2023.578200","author":"S Chhabra","year":"2023","unstructured":"Chhabra, S., Mehan, S., Khan, Z., Gupta, G. D. & Narula, A. S. Matrine mediated neuroprotective potential in experimental multiple sclerosis: Evidence from CSF, blood markers, brain samples and in-silico investigations. J. Neuroimmunol. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578200 (2023).","journal-title":"J. Neuroimmunol."},{"key":"61362_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/genes13081324","author":"S Upadhayay","year":"2022","unstructured":"Upadhayay, S. et al. Nrf2\/HO-1 signaling stimulation through acetyl-11-keto-beta-boswellic acid (AKBA) provides neuroprotection in ethidium bromide-induced experimental model of multiple sclerosis. Genes https:\/\/doi.org\/10.3390\/genes13081324 (2022).","journal-title":"Genes"},{"key":"61362_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2021.100139","author":"A Singh","year":"2021","unstructured":"Singh, A., Upadhayay, S. & Mehan, S. Inhibition of c-JNK\/p38MAPK signaling pathway by apigenin prevents neurobehavioral and neurochemical defects in ethidium bromide-induced experimental model of multiple sclerosis in rats: Evidence from CSF, blood plasma and brain samples. Phytomed. Plus https:\/\/doi.org\/10.1016\/j.phyplu.2021.100139 (2021).","journal-title":"Phytomed. Plus"},{"key":"61362_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-023-04082-9","author":"A Prajapati","year":"2024","unstructured":"Prajapati, A., Mehan, S., Khan, Z., Chhabra, S. & Das Gupta, G. Purmorphamine, a Smo-Shh\/Gli activator, promotes sonic hedgehog-mediated neurogenesis and restores behavioural and neurochemical deficits in experimental model of multiple sclerosis. Neurochem. Res. https:\/\/doi.org\/10.1007\/s11064-023-04082-9 (2024).","journal-title":"Neurochem. Res."},{"key":"61362_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2023.08.001","author":"P Sethi","year":"2023","unstructured":"Sethi, P., Mehan, S., Khan, Z. & Chhabra, S. Acetyl-11-keto-beta boswellic acid (AKBA) modulates CSTC-pathway by activating SIRT-1\/Nrf2-HO-1 signalling in experimental rat model of obsessive-compulsive disorder: Evidenced by CSF, blood plasma and histopathological alterations. Neurotoxicology https:\/\/doi.org\/10.1016\/j.neuro.2023.08.001 (2023).","journal-title":"Neurotoxicology"},{"key":"61362_CR18","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2023.2262580","author":"DA Kadam","year":"2023","unstructured":"Kadam, D. A. et al. Genetic polymorphisms in Nrf2 and FoxO1: Implications for antioxidant enzyme activity in diabetes. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2023.2262580 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"61362_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24050","author":"S Sharma","year":"2024","unstructured":"Sharma, S., Mehan, S., Khan, Z., Gupta, G. D. & Narula, A. S. Icariin prevents methylmercury-induced experimental neurotoxicity: Evidence from cerebrospinal fluid, blood plasma, brain samples, and in-silico investigations. Heliyon https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24050 (2024).","journal-title":"Heliyon"},{"key":"61362_CR20","doi-asserted-by":"publisher","DOI":"10.2174\/1871530321666210309112234","author":"N Sharma","year":"2021","unstructured":"Sharma, N., Shandilya, A., Kumar, N. & Mehan, S. Dysregulation of SIRT-1 signaling in multiple sclerosis and neuroimmune disorders: A systematic review of sirtuin activators as potential immunomodulators and their influences on other dysfunctions. Endocr. Metab. Immune Disord. Drug Targets https:\/\/doi.org\/10.2174\/1871530321666210309112234 (2021).","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"61362_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-026-04820-9","author":"S Gupta","year":"2026","unstructured":"Gupta, S., Mehan, S., Gupta, A. K., Kumar, A., Gupta, G. D., Narula, A. S., Samant, R., & Tongra, M. (2026). Combined Puerarin and Magnesium Acetyl Taurate Intervention Mitigates Autism-Like Pathology Through Glutamatergic and MAPK Pathway Regulation. Neurochemical research, 51(4), 204. https:\/\/doi.org\/10.1007\/s11064-026-04820-9","journal-title":"Neurochemical research"},{"key":"61362_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2021.100051","author":"N Sharma","year":"2021","unstructured":"Sharma, N. et al. Neuroprotection by solanesol against ethidium bromide-induced multiple sclerosis-like neurobehavioral, molecular, and neurochemical alterations in experimental rats. Phytomed. Plus https:\/\/doi.org\/10.1016\/j.phyplu.2021.100051 (2021).","journal-title":"Phytomed. Plus"},{"issue":"11","key":"61362_CR23","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1007\/s11064-021-03366-2","volume":"46","author":"E Minj","year":"2021","unstructured":"Minj, E., Upadhayay, S. & Mehan, S. Nrf2\/HO-1 Signaling Activator Acetyl-11-keto-beta Boswellic Acid (AKBA)-Mediated Neuroprotection in Methyl Mercury-Induced Experimental Model of ALS. Neurochem Res. 46(11), 2867\u20132884. https:\/\/doi.org\/10.1007\/s11064-021-03366-2 (2021).","journal-title":"Neurochem Res."},{"key":"61362_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.dscb.2021.100019","author":"S Upadhayay","year":"2021","unstructured":"Upadhayay, S. & Mehan, S. Targeting Nrf2\/HO-1 anti-oxidant signalling pathway in the progression of multiple sclerosis and influences on neurological dysfunctions. Brain Disord. https:\/\/doi.org\/10.1016\/j.dscb.2021.100019 (2021).","journal-title":"Brain Disord."},{"issue":"1","key":"61362_CR25","doi-asserted-by":"publisher","first-page":"6268514","DOI":"10.1155\/2020\/6268514","volume":"2020","author":"MH Bao","year":"2020","unstructured":"Bao, M. H. et al. A Novel Putative Role of TNK1 in Atherosclerotic Inflammation Implicating the Tyk2\/STAT1 Pathway. Mediators Inflamm. 2020(1), 6268514. https:\/\/doi.org\/10.1155\/2020\/6268514 (2020).","journal-title":"Mediators Inflamm."},{"key":"61362_CR26","doi-asserted-by":"crossref","unstructured":"Geng, L., Gao, W., Saiyin, H., Li, Y., Zeng, Y., Zhang, Z., et al. MLKL deficiency alleviates neuroinflammation and motor deficits in the \u03b1-synuclein transgenic mouse model of Parkinson\u2019s disease. Mol Neurodegener. (2023).","DOI":"10.21203\/rs.3.rs-2996654\/v1"},{"key":"61362_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-022-02272-6","author":"S Kumar","year":"2023","unstructured":"Kumar, S., Mehan, S. & Narula, A. S. Therapeutic modulation of JAK-STAT, mTOR, and PPAR-\u03b3 signaling in neurological dysfunctions. J. Mol. Med. https:\/\/doi.org\/10.1007\/s00109-022-02272-6 (2023).","journal-title":"J. Mol. Med."},{"key":"61362_CR28","doi-asserted-by":"crossref","unstructured":"Kumar, N., Tyagi, N., Mehan, S., Singh, A. P. Enhanced Neuroprotection in Experiment Multiple Sclerosis through Combined Rosiglitazone and Probiotic-loaded Solid Lipid Nanoparticles\u202f: Modulation of Cellular Signaling Pathways. (2024).","DOI":"10.2174\/0118715273336107241015100912"},{"key":"61362_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3030","author":"Y Shan","year":"2023","unstructured":"Shan, Y. et al. Exercise preconditioning attenuates cerebral ischemia-induced neuronal apoptosis, Th17\/Treg imbalance, and inflammation in rats by inhibiting the JAK2\/STAT3 pathway. Brain Behav. https:\/\/doi.org\/10.1002\/brb3.3030 (2023).","journal-title":"Brain Behav."},{"key":"61362_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-023-03902-x","author":"S Kumar","year":"2024","unstructured":"Kumar, S., Mehan, S., Khan, Z., Das Gupta, G. & Narula, A. S. Guggulsterone selectively modulates STAT-3, mTOR, and PPAR-gamma signaling in a methylmercury-exposed experimental neurotoxicity: Evidence from CSF, blood plasma, and brain samples. Mol. Neurobiol. https:\/\/doi.org\/10.1007\/s12035-023-03902-x (2024).","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"61362_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12017-026-08929-6","volume":"28","author":"A Kumar","year":"2026","unstructured":"Kumar, A. et al. Enhanced Neurophysiological Benefits of Magnesium-Acetyl-Taurate Over Magnesium-L-Threonate: A Comparative pre-clinical Study on Bioavailability, Synaptic Plasticity and Cognitive Functions. Neuromolecular Med. 28(1), 25. https:\/\/doi.org\/10.1007\/s12017-026-08929-6 (2026).","journal-title":"Neuromolecular Med."},{"key":"61362_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01484-7","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., Chen, H., Li, R., Sterling, K. & Song, W. Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: Challenges, successes and future. Signal Transduct. Target. Ther. https:\/\/doi.org\/10.1038\/s41392-023-01484-7 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"61362_CR33","doi-asserted-by":"publisher","DOI":"10.2174\/1567205017666201007120112","author":"P Duggal","year":"2020","unstructured":"Duggal, P., Jadaun, K. S., Siqqiqui, E. M. & Mehan, S. Investigation of low dose cabazitaxel potential as microtubule stabilizer in experimental model of Alzheimer\u2019s disease: Restoring neuronal cytoskeleton. Curr. Alzheimer Res. https:\/\/doi.org\/10.2174\/1567205017666201007120112 (2020).","journal-title":"Curr. Alzheimer Res."},{"key":"61362_CR34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA117.001387","author":"W Wang","year":"2018","unstructured":"Wang, W. et al. JAK1-mediated Sirt1 phosphorylation functions as a negative feedback of the JAK1-STAT3 pathway. J. Biol. Chem. https:\/\/doi.org\/10.1074\/jbc.RA117.001387 (2018).","journal-title":"J. Biol. Chem."},{"key":"61362_CR35","doi-asserted-by":"publisher","DOI":"10.1080\/19768354.2020.1726461","author":"JW Kim","year":"2020","unstructured":"Kim, J. W., Yang, J. H. & Kim, E. J. SIRT1 and AROS suppress doxorubicin-induced apoptosis via inhibition of GSK3\u03b2 activity in neuroblastoma cells. Anim. Cells Syst. https:\/\/doi.org\/10.1080\/19768354.2020.1726461 (2020).","journal-title":"Anim. Cells Syst."},{"key":"61362_CR36","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.40463","author":"DI Razick","year":"2023","unstructured":"Razick, D. I. et al. The role of sirtuin 1 (SIRT1) in neurodegeneration. Cureus https:\/\/doi.org\/10.7759\/cureus.40463 (2023).","journal-title":"Cureus"},{"key":"61362_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.595634","author":"K Yang","year":"2021","unstructured":"Yang, K. & Dong, W. SIRT1-related signaling pathways and their association with bronchopulmonary dysplasia. Front. Med. https:\/\/doi.org\/10.3389\/fmed.2021.595634 (2021).","journal-title":"Front. Med."},{"key":"61362_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01333-9","author":"L Xu","year":"2022","unstructured":"Xu, L. et al. Cur@SF NPs alleviate Friedreich\u2019s ataxia in a mouse model through synergistic iron chelation and antioxidation. J. Nanobiotechnol. https:\/\/doi.org\/10.1186\/s12951-022-01333-9 (2022).","journal-title":"J. Nanobiotechnol."},{"key":"61362_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28247955","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Palmatine protects PC12 cells and mice from A\u03b225-35-induced oxidative stress and neuroinflammation via the Nrf2\/HO-1 pathway. Molecules https:\/\/doi.org\/10.3390\/molecules28247955 (2023).","journal-title":"Molecules"},{"key":"61362_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.848813","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. Echinacoside protects dopaminergic neurons through regulating IL-6\/JAK2\/STAT3 pathway in Parkinson\u2019s disease model. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.848813 (2022).","journal-title":"Front. Pharmacol."},{"key":"61362_CR41","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10029","author":"R Luo","year":"2021","unstructured":"Luo, R. et al. Dl-butylphthalide inhibits rotenone-induced oxidative stress in microglia via regulation of the Keap1\/Nrf2\/HO-1 signaling pathway. Exp. Ther. Med. https:\/\/doi.org\/10.3892\/etm.2021.10029 (2021).","journal-title":"Exp. Ther. Med."},{"key":"61362_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/973298","author":"J Lange","year":"2015","unstructured":"Lange, J. et al. Association of a BACE1 gene polymorphism with Parkinson\u2019s disease in a Norwegian population. Parkinsons Dis. https:\/\/doi.org\/10.1155\/2015\/973298 (2015).","journal-title":"Parkinsons Dis."},{"key":"61362_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2014.107","author":"Y Gao","year":"2015","unstructured":"Gao, Y. et al. Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington\u2019s disease. Acta Pharmacol. Sin. https:\/\/doi.org\/10.1038\/aps.2014.107 (2015).","journal-title":"Acta Pharmacol. Sin."},{"key":"61362_CR44","doi-asserted-by":"publisher","DOI":"10.1159\/000497820","author":"P Origone","year":"2019","unstructured":"Origone, P. et al. Role of MAPT in pure motor neuron disease: Report of a recurrent mutation in Italian patients. Neurodegener. Dis. https:\/\/doi.org\/10.1159\/000497820 (2019).","journal-title":"Neurodegener. Dis."},{"key":"61362_CR45","doi-asserted-by":"crossref","unstructured":"Erten, F. Lycopene ameliorates propionic acid-induced autism spectrum disorders by inhibiting inflammation and oxidative stress in rats. J. Food Biochem. (2021).","DOI":"10.1111\/jfbc.13922"},{"key":"61362_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27030889","author":"R Khera","year":"2022","unstructured":"Khera, R. et al. Guggulsterone mediated JAK\/STAT and PPAR-gamma modulation prevents neurobehavioral and neurochemical abnormalities in propionic acid-induced experimental model of autism. Molecules https:\/\/doi.org\/10.3390\/molecules27030889 (2022).","journal-title":"Molecules"},{"key":"61362_CR47","doi-asserted-by":"crossref","unstructured":"Dang, R., Wang, M., Li, X., Wang, H., Liu, L., Wu, Q., et al. Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1\/Nrf2\/HO-1\/Gpx4 pathway. J Neuroinflammation. (2022).","DOI":"10.21203\/rs.3.rs-850484\/v1"},{"key":"61362_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-022-08219-x","author":"H Mojiri-Forushani","year":"2023","unstructured":"Mojiri-Forushani, H., Khajehali, E., Adelipour, M. & Mohammadi, A. Inhibitory effects of fluoxetine on the secretion of inflammatory mediators and JAK\/STAT3 and JNK\/TLR4 gene expression. Mol. Biol. Rep. https:\/\/doi.org\/10.1007\/s11033-022-08219-x (2023).","journal-title":"Mol. Biol. Rep."},{"key":"61362_CR49","doi-asserted-by":"publisher","first-page":"175801","DOI":"10.1016\/j.ejphar.2023.175801","volume":"951","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. A comparative study of the neuroprotective effects of dl-3-n-butylphthalide and edaravone dexborneol on cerebral ischemic stroke rats. Eur. J. Pharmacol. 951, 175801 (2023).","journal-title":"Eur. J. Pharmacol."},{"key":"61362_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2018.03.020","author":"W Dai","year":"2018","unstructured":"Dai, W. et al. Curcumin provides neuroprotection in model of traumatic brain injury via the Nrf2-ARE signaling pathway. Brain Res. Bull. https:\/\/doi.org\/10.1016\/j.brainresbull.2018.03.020 (2018).","journal-title":"Brain Res. Bull."},{"key":"61362_CR51","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7191080","author":"V Pegoretti","year":"2020","unstructured":"Pegoretti, V. et al. Inflammation and oxidative stress in multiple sclerosis: Consequences for therapy development. Oxid. Med. Cell. Longev. https:\/\/doi.org\/10.1155\/2020\/7191080 (2020).","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2","key":"61362_CR52","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s10787-024-01442-x","volume":"32","author":"MA Nicola","year":"2024","unstructured":"Nicola, M. A., Attaai, A. H., Abdel-Raheem, M. H., Mohammed, A. F. & Abu-Elhassan, Y. F. Neuroprotective effects of rutin against cuprizone-induced multiple sclerosis in mice. Inflammopharmacology 32(2), 1295\u20131315. https:\/\/doi.org\/10.1007\/s10787-024-01442-x (2024).","journal-title":"Inflammopharmacology"},{"key":"61362_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14010012","author":"SM Safwat","year":"2024","unstructured":"Safwat, S. M. et al. Vanillic acid ameliorates demyelination in a cuprizone-induced multiple sclerosis rat model: Possible underlying mechanisms. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci14010012 (2024).","journal-title":"Brain Sci."},{"key":"61362_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-023-01399-3","author":"MA Sadek","year":"2024","unstructured":"Sadek, M. A., Rabie, M. A., El Sayed, N. S., Sayed, H. M. & Kandil, E. A. Neuroprotective effect of curcumin against experimental autoimmune encephalomyelitis-induced cognitive and physical impairments in mice: An insight into the role of the AMPK\/SIRT1 pathway. Inflammopharmacology https:\/\/doi.org\/10.1007\/s10787-023-01399-3 (2024).","journal-title":"Inflammopharmacology"},{"key":"61362_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-024-02099-y","author":"N Wu","year":"2024","unstructured":"Wu, N. et al. Methylprednisolone Modulates the Tfr\/Tfh ratio in EAE-Induced Neuroinflammation through the PI3K\/AKT\/FoxO1 and PI3K\/AKT\/mTOR Signalling Pathways. Inflammation https:\/\/doi.org\/10.1007\/s10753-024-02099-y (2024).","journal-title":"Inflammation"},{"key":"61362_CR56","doi-asserted-by":"crossref","unstructured":"Bruno, A., Dolcetti, E., Azzolini, F., Buttari, F., Gilio, L., Iezzi, E., et al. BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis. Mult Scler Relat Disord. (2023).","DOI":"10.1016\/j.msard.2023.104528"},{"key":"61362_CR57","doi-asserted-by":"crossref","unstructured":"Virgilio, E., Vecchio, D., Crespi, I., Serino, R., Cantello, R., Dianzani, U., et al. Cerebrospinal Tau levels as a predictor of early disability in multiple sclerosis. Mult Scler Relat Disord. (2021).","DOI":"10.21203\/rs.3.rs-359282\/v1"},{"key":"61362_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01444-2","author":"MS LaCroix","year":"2022","unstructured":"LaCroix, M. S. et al. Tau seeding in cases of multiple sclerosis. Acta Neuropathol. Commun. https:\/\/doi.org\/10.1186\/s40478-022-01444-2 (2022).","journal-title":"Acta Neuropathol. Commun."},{"key":"61362_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2007.09.007","author":"M Jurynczyk","year":"2008","unstructured":"Jurynczyk, M., Jurewicz, A., Bielecki, B., Raine, C. S. & Selmaj, K. Overcoming failure to repair demyelination in EAE: \u03b3-secretase inhibition of Notch signaling. J. Neurol. Sci. https:\/\/doi.org\/10.1016\/j.jns.2007.09.007 (2008).","journal-title":"J. Neurol. Sci."},{"key":"61362_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8333","author":"SA Laurent","year":"2015","unstructured":"Laurent, S. A. et al. \u03b3-secretase directly sheds the survival receptor BCMA from plasma cells. Nat. Commun. https:\/\/doi.org\/10.1038\/ncomms8333 (2015).","journal-title":"Nat. Commun."},{"issue":"1","key":"61362_CR61","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1080\/13880209.2023.2229379","volume":"61","author":"E Hu","year":"2023","unstructured":"Hu, E. et al. Metabolomics reveals the effects of hydroxysafflor yellow A on neurogenesis and axon regeneration after experimental traumatic brain injury. Pharm Biol. 61(1), 1054\u20131064. https:\/\/doi.org\/10.1080\/13880209.2023.2229379 (2023).","journal-title":"Pharm Biol."},{"key":"61362_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194796","author":"AE Kaiser","year":"2021","unstructured":"Kaiser, A. E. et al. Sulforaphane: A broccoli bioactive phytocompound with cancer preventive potential. Cancers https:\/\/doi.org\/10.3390\/cancers13194796 (2021).","journal-title":"Cancers"},{"key":"61362_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14520-8","author":"E Kubo","year":"2017","unstructured":"Kubo, E., Chhunchha, B., Singh, P., Sasaki, H. & Singh, D. P. Sulforaphane reactivates cellular antioxidant defense by inducing Nrf2\/ARE\/Prdx6 activity during aging and oxidative stress. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-017-14520-8 (2017).","journal-title":"Sci. Rep."},{"key":"61362_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9060521","author":"RT Ruhee","year":"2020","unstructured":"Ruhee, R. T. & Suzuki, K. The integrative role of sulforaphane in preventing inflammation, oxidative stress and fatigue: A review of a potential protective phytochemical. Antioxidants https:\/\/doi.org\/10.3390\/antiox9060521 (2020).","journal-title":"Antioxidants"},{"key":"61362_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1089115","author":"LdeL Coutinho","year":"2023","unstructured":"Coutinho, LdeL., Junior, T. C. T. & Rangel, M. C. Sulforaphane: An emergent anti-cancer stem cell agent. Front. Oncol. https:\/\/doi.org\/10.3389\/fonc.2023.1089115 (2023).","journal-title":"Front. Oncol."},{"key":"61362_CR66","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-019-00061-7","author":"R Sant\u00edn-M\u00e1rquez","year":"2019","unstructured":"Sant\u00edn-M\u00e1rquez, R., Alarc\u00f3n-Aguilar, A., L\u00f3pez-Diazguerrero, N. E., Chondrogianni, N. & K\u00f6nigsberg, M. Sulforaphane - role in aging and neurodegeneration. GeroScience https:\/\/doi.org\/10.1007\/s11357-019-00061-7 (2019).","journal-title":"GeroScience"},{"key":"61362_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00121","author":"J Zhang","year":"2017","unstructured":"Zhang, J. et al. Beneficial effects of sulforaphane treatment in Alzheimer\u2019s disease may be mediated through reduced HDAC1\/3 and increased P75NTR expression. Front. Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2017.00121 (2017).","journal-title":"Front. Aging Neurosci."},{"key":"61362_CR68","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12647","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Sulforaphane enhances proteasomal and autophagic activities in mice and is a potential therapeutic reagent for Huntington\u2019s disease. J. Neurochem. https:\/\/doi.org\/10.1111\/jnc.12647 (2014).","journal-title":"J. Neurochem."},{"key":"61362_CR69","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuro.2013.03.004","volume":"36","author":"F Morroni","year":"2013","unstructured":"Morroni, F. et al. Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson\u2019s disease. Neurotoxicology 36, 63\u201371. https:\/\/doi.org\/10.1016\/j.neuro.2013.03.004 (2013).","journal-title":"Neurotoxicology"},{"key":"61362_CR70","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2015.13.1.62","author":"A Shiina","year":"2015","unstructured":"Shiina, A. et al. An open study of sulforaphane-rich broccoli sprout extract in patients with schizophrenia. Clin. Psychopharmacol. Neurosci. https:\/\/doi.org\/10.9758\/cpn.2015.13.1.62 (2015).","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"61362_CR71","doi-asserted-by":"crossref","unstructured":"Zimmerman, A. W., Singh, K., Connors, S. L., Liu, H., Panjwani, A. A., Lee, L. C., et al. Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder. Mol Autism. (2021).","DOI":"10.1186\/s13229-021-00451-9"},{"key":"61362_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ph17060762","author":"P Pa\u0144czyszyn-Trzewik","year":"2024","unstructured":"Pa\u0144czyszyn-Trzewik, P., Stachowicz, K., Misztak, P., Nowak, G. & Sowa-Ku\u0107ma, M. Repeated sulforaphane treatment reverses depressive-like behavior and exerts antioxidant effects in the olfactory bulbectomy model in mice. Pharmaceuticals (Basel) https:\/\/doi.org\/10.3390\/ph17060762 (2024).","journal-title":"Pharmaceuticals (Basel)"},{"key":"61362_CR73","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020981","author":"C Wu","year":"2020","unstructured":"Wu, C., Chen, X., Lai, J., Xu, Y. & Hu, S. The efficacy and safety of sulforaphane as an adjuvant in the treatment of bipolar depressive disorder: Study protocol for a randomized, double-blinded, placebo-controlled, parallel-group clinical trial. Medicine (Baltimore) https:\/\/doi.org\/10.1097\/MD.0000000000020981 (2020).","journal-title":"Medicine (Baltimore)"},{"key":"61362_CR74","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12277","author":"Y Bai","year":"2017","unstructured":"Bai, Y. et al. Sulforaphane protection against the development of doxorubicin-induced chronic heart failure is associated with Nrf2 upregulation. Cardiovasc. Ther. https:\/\/doi.org\/10.1111\/1755-5922.12277 (2017).","journal-title":"Cardiovasc. Ther."},{"key":"61362_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.12.009","author":"Z Lu","year":"2021","unstructured":"Lu, Z. et al. Inhibiting autophagy enhances sulforaphane-induced apoptosis via targeting NRF2 in esophageal squamous cell carcinoma. Acta Pharm. Sin. B https:\/\/doi.org\/10.1016\/j.apsb.2020.12.009 (2021).","journal-title":"Acta Pharm. Sin. B"},{"key":"61362_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2022.10.001","author":"Q Li","year":"2022","unstructured":"Li, Q., Fadoul, G., Ikonomovic, M., Yang, T. & Zhang, F. Sulforaphane promotes white matter plasticity and improves long-term neurological outcomes after ischemic stroke via the Nrf2 pathway. Free Radic. Biol. Med. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.10.001 (2022).","journal-title":"Free Radic. Biol. Med."},{"key":"61362_CR77","unstructured":"Thangapandiyan, S., Ramesh, M., Hema, T., Miltonprabu, S., Uddin, M. S., Nandhini, V., et al. Sulforaphane potentially ameliorates arsenic induced hepatotoxicity in Albino Wistar rats: Implication of PI3K\/Akt\/Nrf2 signaling pathway. Cell Physiol Biochem. (2019)."},{"key":"61362_CR78","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12251","author":"M Chen","year":"2021","unstructured":"Chen, M., Huang, L., Lv, Y., Li, L. & Dong, Q. Sulforaphane protects against oxidative stress-induced apoptosis via activating SIRT1 in mouse osteoarthritis. Mol. Med. Rep. https:\/\/doi.org\/10.3892\/mmr.2021.12251 (2021).","journal-title":"Mol. Med. Rep."},{"key":"61362_CR79","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-15-0290","author":"JE Bauman","year":"2016","unstructured":"Bauman, J. E. et al. Prevention of carcinogen-induced oral cancer by sulforaphane. Cancer Prev. Res. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-15-0290 (2016).","journal-title":"Cancer Prev. Res."},{"key":"61362_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06234-9","author":"C Ma","year":"2023","unstructured":"Ma, C. et al. Sulforaphane alleviates psoriasis by enhancing antioxidant defense through KEAP1-NRF2 pathway activation and attenuating inflammatory signaling. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-023-06234-9 (2023).","journal-title":"Cell Death Dis."},{"key":"61362_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53836-0","author":"W Fan","year":"2024","unstructured":"Fan, W. et al. NRF2 activation ameliorates blood\u2013brain barrier injury after cerebral ischemic stroke by regulating ferroptosis and inflammation. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-024-53836-0 (2024).","journal-title":"Sci. Rep."},{"key":"61362_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep32206","volume":"6","author":"Q Zhou","year":"2016","unstructured":"Zhou, Q. et al. Sulforaphane protects against rotenone-induced neurotoxicity in vivo: Involvement of the mTOR, Nrf2, and autophagy pathways. Sci. Rep. 6, 1\u201312. https:\/\/doi.org\/10.1038\/srep32206 (2016).","journal-title":"Sci. Rep."},{"key":"61362_CR83","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-015-9230-2","author":"M Jang","year":"2016","unstructured":"Jang, M. & Cho, I. H. Sulforaphane ameliorates 3-nitropropionic acid-induced striatal toxicity by activating the Keap1-Nrf2-ARE pathway and inhibiting the MAPKs and NF-\u03baB pathways. Mol. Neurobiol. https:\/\/doi.org\/10.1007\/s12035-015-9230-2 (2016).","journal-title":"Mol. Neurobiol."},{"key":"61362_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127244","author":"Y Shirai","year":"2015","unstructured":"Shirai, Y. et al. Dietary intake of sulforaphane-rich broccoli sprout extracts during juvenile and adolescence can prevent phencyclidine-induced cognitive deficits at adulthood. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0127244 (2015).","journal-title":"PLoS ONE"},{"key":"61362_CR85","doi-asserted-by":"publisher","DOI":"10.1093\/schizbullopen\/sgac024","author":"G Hei","year":"2022","unstructured":"Hei, G. et al. Sulforaphane effects on cognition and symptoms in first and early episode schizophrenia: A randomized double-blind trial. Schizophr. Bull. Open https:\/\/doi.org\/10.1093\/schizbullopen\/sgac024 (2022).","journal-title":"Schizophr. Bull. Open"},{"key":"61362_CR86","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.bbr.2019.02.031","volume":"364","author":"A Nadeem","year":"2019","unstructured":"Nadeem, A. et al. Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf\/J mice. Behav Brain Res. 364, 213\u2013224. https:\/\/doi.org\/10.1016\/j.bbr.2019.02.031 (2019).","journal-title":"Behav Brain Res."},{"key":"61362_CR87","doi-asserted-by":"publisher","DOI":"10.1111\/eip.12988","author":"Z Li","year":"2021","unstructured":"Li, Z. et al. Decreasing risk of psychosis by sulforaphane study protocol for a randomized, double-blind, placebo-controlled, clinical multi-centre trial. Early Interv. Psychiatry https:\/\/doi.org\/10.1111\/eip.12988 (2021).","journal-title":"Early Interv. Psychiatry"},{"key":"61362_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2013.10.002","author":"B Li","year":"2013","unstructured":"Li, B. et al. Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice. Exp. Neurol. https:\/\/doi.org\/10.1016\/j.expneurol.2013.10.002 (2013).","journal-title":"Exp. Neurol."},{"key":"61362_CR89","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2019.34.e197","author":"IH Yoo","year":"2019","unstructured":"Yoo, I. H. et al. The anti-inflammatory effect of sulforaphane in mice with experimental autoimmune encephalomyelitis. J. Korean Med. Sci. https:\/\/doi.org\/10.3346\/jkms.2019.34.e197 (2019).","journal-title":"J. Korean Med. Sci."},{"key":"61362_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.02.027","author":"I Galea","year":"2019","unstructured":"Galea, I., Copple, I. M., Howat, D. W. & Franklin, S. SFX-01 reduces residual disability after experimental autoimmune encephalomyelitis. Mult. Scler. Relat. Disord. https:\/\/doi.org\/10.1016\/j.msard.2019.02.027 (2019).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"61362_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2005.05.013","author":"A Wierinckx","year":"2005","unstructured":"Wierinckx, A. et al. Detoxication enzyme inducers modify cytokine production in rat mixed glial cells. J. Neuroimmunol. https:\/\/doi.org\/10.1016\/j.jneuroim.2005.05.013 (2005).","journal-title":"J. Neuroimmunol."},{"key":"61362_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23666-z","author":"C Hohenfeld","year":"2022","unstructured":"Hohenfeld, C. et al. Prediction of the disease course in Friedreich ataxia. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-022-23666-z (2022).","journal-title":"Sci. Rep."},{"key":"61362_CR93","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29286","author":"DR Lynch","year":"2023","unstructured":"Lynch, D. R. et al. Efficacy of Omaveloxolone in Friedreich\u2019s ataxia: Delayed-start analysis of the MOXIe extension. Mov. Disord. https:\/\/doi.org\/10.1002\/mds.29286 (2023).","journal-title":"Mov. Disord."},{"key":"61362_CR94","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25934","author":"DR Lynch","year":"2021","unstructured":"Lynch, D. R. et al. Safety and efficacy of Omaveloxolone in Friedreich ataxia (MOXIe study). Ann. Neurol. https:\/\/doi.org\/10.1002\/ana.25934 (2021).","journal-title":"Ann. Neurol."},{"key":"61362_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00188","author":"R Abeti","year":"2018","unstructured":"Abeti, R., Baccaro, A., Esteras, N. & Giunti, P. Novel Nrf2-inducer prevents mitochondrial defects and oxidative stress in Friedreich\u2019s ataxia models. Front. Cell. Neurosci. https:\/\/doi.org\/10.3389\/fncel.2018.00188 (2018).","journal-title":"Front. Cell. Neurosci."},{"key":"61362_CR96","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4564471","author":"L Hu","year":"2022","unstructured":"Hu, L. et al. The novel Nrf2 activator omaveloxolone regulates microglia phenotype and ameliorates secondary brain injury after intracerebral hemorrhage in mice. Oxid. Med. Cell. Longev. https:\/\/doi.org\/10.1155\/2022\/4564471 (2022).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"61362_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122261","author":"X Cui","year":"2023","unstructured":"Cui, X. et al. Omaveloxolone ameliorates cognitive dysfunction in APP\/PS1 mice by stabilizing the STAT3 pathway. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2023.122261 (2023).","journal-title":"Life Sci."},{"key":"61362_CR98","doi-asserted-by":"crossref","unstructured":"Shigri AF, Alvi AM, Ali A, Qureshi A, Malikzai A. Omaveloxolone: a drug providing a promising avenue for the treatment of Friedreich\u2019s ataxia. Int J Surg Glob Heal. 2023;","DOI":"10.1097\/GH9.0000000000000217"},{"key":"61362_CR99","doi-asserted-by":"crossref","unstructured":"Carlstr\u00f6m, K. E., Ewing, E., Granqvist, M., Gyllenberg, A., Aeinehband, S., Enoksson, S. L., et al. Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes. Nat Commun. (2019).","DOI":"10.1038\/s41467-019-11139-3"},{"key":"61362_CR100","doi-asserted-by":"crossref","unstructured":"ROS EO. The US FDA-Approved Drug Dimethyl Fumarate, an Nrf2 Activator, for Treating Multiple Sclerosis: The Mechanisms of Action Revisited. React Oxyg Species. (2021).","DOI":"10.20455\/ros.2021.n.807"},{"key":"61362_CR101","doi-asserted-by":"publisher","DOI":"10.1177\/13524585211037909","author":"R Gold","year":"2022","unstructured":"Gold, R. et al. Long-term safety and efficacy of dimethyl fumarate for up to 13 years in patients with relapsing-remitting multiple sclerosis: Final ENDORSE study results. Mult. Scler. J. https:\/\/doi.org\/10.1177\/13524585211037909 (2022).","journal-title":"Mult. Scler. J."},{"key":"61362_CR102","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.30439","author":"P Vermersch","year":"2022","unstructured":"Vermersch, P. et al. Effect of dimethyl fumarate versus interferon \u03b2-1a in patients with pediatric-onset multiple sclerosis: The CONNECT randomized clinical trial. JAMA Netw. Open https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.30439 (2022).","journal-title":"JAMA Netw. Open"},{"key":"61362_CR103","unstructured":"Chow, H. H., Talbot, J., Lundell, H., Madsen, C. G., Marstrand, L., Lange, T., et al. Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis: A Randomized, Controlled Trial. Neurol. Neuroimmunol. NeuroInflammation. (2021)."},{"key":"61362_CR104","doi-asserted-by":"crossref","unstructured":"Holm Hansen, R., H\u00f8jsgaard Chow, H., Christensen, J. R., Sellebjerg, F., von Essen MR. Dimethyl fumarate therapy reduces memory T cells and the CNS migration potential in patients with multiple sclerosis. Mult Scler Relat Disord. (2020).","DOI":"10.1016\/j.msard.2019.101451"},{"key":"61362_CR105","doi-asserted-by":"publisher","DOI":"10.1177\/2055217319887191","author":"T Berger","year":"2019","unstructured":"Berger, T. et al. Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing\u2013remitting multiple sclerosis in a real-world clinical setting: PROTEC. Mult. Scler. J. Exp. Transl. Clin. https:\/\/doi.org\/10.1177\/2055217319887191 (2019).","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"61362_CR106","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114287","author":"R Gold","year":"2012","unstructured":"Gold, R. et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa1114287 (2012).","journal-title":"N. Engl. J. Med."},{"key":"61362_CR107","doi-asserted-by":"publisher","DOI":"10.1080\/08927022.2023.2256624","author":"S Kumar","year":"2023","unstructured":"Kumar, S. et al. In-silico and in-vitro identification of triazole based compounds as potential EGFR inhibitors targeting lung cancer. Mol. Simul. https:\/\/doi.org\/10.1080\/08927022.2023.2256624 (2023).","journal-title":"Mol. Simul."},{"key":"61362_CR108","doi-asserted-by":"publisher","DOI":"10.1007\/s40203-023-00157-1","author":"S Kumar","year":"2023","unstructured":"Kumar, S. et al. In-silico identification of small molecule benzofuran-1,2,3-triazole hybrids as potential inhibitors targeting EGFR in lung cancer via ligand-based pharmacophore modeling and molecular docking studies. In Silico Pharmacol. https:\/\/doi.org\/10.1007\/s40203-023-00157-1 (2023).","journal-title":"In Silico Pharmacol."},{"key":"61362_CR109","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-024-10817-9","author":"S Kumar","year":"2024","unstructured":"Kumar, S. et al. In-silico identification and exploration of small molecule coumarin-1,2,3-triazole hybrids as potential EGFR inhibitors for targeting lung cancer. Mol. Divers. https:\/\/doi.org\/10.1007\/s11030-024-10817-9 (2024).","journal-title":"Mol. Divers."},{"key":"61362_CR110","doi-asserted-by":"crossref","unstructured":"Morris, G. M., Ruth, H., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., et al. Software news and updates AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. (2009).","DOI":"10.1002\/jcc.21256"},{"key":"61362_CR111","doi-asserted-by":"crossref","unstructured":"Dallakyan, S., Olson, A. J. Small-molecule library screening by docking with PyRx. Methods Mol Biol. (2015).","DOI":"10.1007\/978-1-4939-2269-7_19"},{"key":"61362_CR112","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2023.2204360","author":"S Kumar","year":"2023","unstructured":"Kumar, S. et al. Identification and exploration of quinazoline-1,2,3-triazole inhibitors targeting EGFR in lung cancer. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2023.2204360 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"61362_CR113","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.660","author":"DR Lynch","year":"2019","unstructured":"Lynch, D. R. et al. Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia. Ann. Clin. Transl. Neurol. https:\/\/doi.org\/10.1002\/acn3.660 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"Keap 1","key":"61362_CR114","first-page":"1","volume":"2","author":"J Singh","year":"2022","unstructured":"Singh, J. et al. Dimethyl fumarate ameliorates paclitaxel-induced neuropathic pain in rats. Cureus 2(Keap 1), 1\u201312 (2022).","journal-title":"Cureus"},{"key":"61362_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2014.05.003","author":"S Lee","year":"2014","unstructured":"Lee, S. et al. Sulforaphane alleviates scopolamine-induced memory impairment in mice. Pharmacol. Res. https:\/\/doi.org\/10.1016\/j.phrs.2014.05.003 (2014).","journal-title":"Pharmacol. Res."},{"key":"61362_CR116","doi-asserted-by":"crossref","unstructured":"Li, B., Cui, W., Liu, J., Li, R., Liu, Q., Xie, X. H., et al. Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related in fl ammation in mice. 250:239\u201349. (2013).","DOI":"10.1016\/j.expneurol.2013.10.002"},{"key":"61362_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/cells11182771","author":"T Kapoor","year":"2022","unstructured":"Kapoor, T. et al. Forskolin, an adenylcyclase\/cAMP\/CREB signaling activator restoring myelin-associated oligodendrocyte destruction in experimental ethidium bromide model of multiple sclerosis. Cells https:\/\/doi.org\/10.3390\/cells11182771 (2022).","journal-title":"Cells"},{"key":"61362_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2022.102296","author":"S Bhalla","year":"2022","unstructured":"Bhalla, S. & Mehan, S. 4-hydroxyisoleucine mediated IGF-1\/GLP-1 signalling activation prevents propionic acid-induced autism-like behavioural phenotypes and neurochemical defects in experimental rats. Neuropeptides https:\/\/doi.org\/10.1016\/j.npep.2022.102296 (2022).","journal-title":"Neuropeptides"},{"issue":"4","key":"61362_CR119","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s11064-026-04820-9","volume":"51","author":"S Gupta","year":"2026","unstructured":"Gupta, S. et al. Combined Puerarin and Magnesium Acetyl Taurate Intervention Mitigates Autism-Like Pathology Through Glutamatergic and MAPK Pathway Regulation. Neurochem. Res. 51(4), 204. https:\/\/doi.org\/10.1007\/s11064-026-04820-9 (2026).","journal-title":"Neurochem. Res."},{"key":"61362_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2022.04.023","author":"R Sahu","year":"2022","unstructured":"Sahu, R. et al. Effect of alpha-mangostin in the prevention of behavioural and neurochemical defects in methylmercury-induced neurotoxicity in experimental rats. Toxicol. Rep. https:\/\/doi.org\/10.1016\/j.toxrep.2022.04.023 (2022).","journal-title":"Toxicol. Rep."},{"key":"61362_CR121","doi-asserted-by":"crossref","unstructured":"Tiwari, A., Khera, R., Rahi, S., Mehan, S., Makeen, H. A., Khormi, Y. H., et al. Neuroprotective effect of \u03b1\u2010mangostin in the ameliorating propionic acid\u2010induced experimental model of autism in wistar rats. Brain Sci. (2021).","DOI":"10.3390\/brainsci11030288"},{"key":"61362_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12030342","author":"R Gupta","year":"2022","unstructured":"Gupta, R. et al. Smo-Shh agonist purmorphamine prevents neurobehavioral and neurochemical defects in 8-OH-DPAT-induced experimental model of obsessive-compulsive disorder. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci12030342 (2022).","journal-title":"Brain Sci."},{"key":"61362_CR123","doi-asserted-by":"publisher","first-page":"105876","DOI":"10.1016\/j.neuint.2024.105876","volume":"180","author":"R Sharma","year":"2024","unstructured":"Sharma, R., Mehan, S., Khan, Z., Das Gupta, G. & Narula, A. S. Therapeutic potential of oleanolic acid in modulation of PI3K\/Akt\/mTOR\/STAT-3\/GSK-3\u03b2 signaling pathways and neuroprotection against methylmercury-induced neurodegeneration. Neurochem Int. 180, 105876. https:\/\/doi.org\/10.1016\/j.neuint.2024.105876 (2024).","journal-title":"Neurochem Int."},{"key":"61362_CR124","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04351-w","author":"MS Khan","year":"2024","unstructured":"Khan, M. S. et al. Synthesis and Neurobehavioral Evaluation of a Potent Multitargeted Inhibitor for the Treatment of Alzheimer\u2019s Disease. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-024-04351-w (2024).","journal-title":"Mol Neurobiol."},{"issue":"7","key":"61362_CR125","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2174\/1567205017666201007120112","volume":"17","author":"P Duggal","year":"2020","unstructured":"Duggal, P., Jadaun, K. S., Siqqiqui, E. M. & Mehan, S. Investigation of low dose cabazitaxel potential as microtubule stabilizer in experimental model of Alzheimer\u2019s disease: Restoring neuronal cytoskeleton. Curr. Alzheimer Res. 17(7), 601\u2013615 (2020).","journal-title":"Curr. Alzheimer Res."},{"key":"61362_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27123878","author":"A Shandilya","year":"2022","unstructured":"Shandilya, A. et al. Activation of IGF-1\/GLP-1 signalling via 4-hydroxyisoleucine prevents motor neuron impairments in experimental ALS-rats exposed to methylmercury-induced neurotoxicity. Molecules https:\/\/doi.org\/10.3390\/molecules27123878 (2022).","journal-title":"Molecules"},{"key":"61362_CR127","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-022-2522-7","author":"KS Jadaun","year":"2022","unstructured":"Jadaun, K. S. et al. Neuroprotective effect of chrysophanol as a PI3K\/AKT\/mTOR signaling inhibitor in an experimental model of autologous blood-induced intracerebral hemorrhage. Curr. Med. Sci. https:\/\/doi.org\/10.1007\/s11596-022-2522-7 (2022).","journal-title":"Curr. Med. Sci."},{"key":"61362_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27227951","author":"M Alharbi","year":"2022","unstructured":"Alharbi, M. et al. Effect of natural adenylcyclase\/cAMP\/CREB signalling activator forskolin against intra-striatal 6-OHDA-lesioned Parkinson\u2019s rats: Preventing mitochondrial, motor and histopathological defects. Molecules https:\/\/doi.org\/10.3390\/molecules27227951 (2022).","journal-title":"Molecules"},{"key":"61362_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2019.10.019","author":"R Sharma","year":"2019","unstructured":"Sharma, R., Rahi, S. & Mehan, S. Neuroprotective potential of solanesol in intracerebroventricular propionic acid induced experimental model of autism: Insights from behavioral and biochemical evidence. Toxicol. Rep. https:\/\/doi.org\/10.1016\/j.toxrep.2019.10.019 (2019).","journal-title":"Toxicol. Rep."},{"key":"61362_CR130","doi-asserted-by":"publisher","DOI":"10.1177\/09603271211013456","author":"S Rahi","year":"2021","unstructured":"Rahi, S., Gupta, R., Sharma, A. & Mehan, S. Smo-Shh signaling activator purmorphamine ameliorates neurobehavioral, molecular, and morphological alterations in an intracerebroventricular propionic acid-induced experimental model of autism. Hum. Exp. Toxicol. https:\/\/doi.org\/10.1177\/09603271211013456 (2021).","journal-title":"Hum. Exp. Toxicol."},{"key":"61362_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.ibror.2020.03.001","author":"K Rajdev","year":"2020","unstructured":"Rajdev, K., Siddiqui, E. M., Jadaun, K. S. & Mehan, S. Neuroprotective potential of solanesol in a combined model of intracerebral and intraventricular hemorrhage in rats. IBRO Rep. https:\/\/doi.org\/10.1016\/j.ibror.2020.03.001 (2020).","journal-title":"IBRO Rep."},{"key":"61362_CR132","doi-asserted-by":"crossref","unstructured":"Sherawat, K., Mehan, S., Khan, Z., Tiwari, A., Gupta, G. Das, Narula, A. S. Neuroprotective Potential of Tanshinone-IIA in Mitigating Propionic Acid- induced Experimental Autism-like Behavioral and Neurochemical Alterations\u202f: Insights into c-JNK and p38MAPK Pathways. pp. 1\u201332. (2024).","DOI":"10.2174\/0118761429326799241121104310"},{"key":"61362_CR133","doi-asserted-by":"publisher","DOI":"10.2174\/1573407216999200723113054","author":"MM Alam","year":"2020","unstructured":"Alam, M. M., Minj, E., Yadav, R. K. & Mehan, S. Neuroprotective potential of adenyl cyclase\/cAMP\/CREB and mitochondrial CoQ10 activator in amyotrophic lateral sclerosis rats. Curr. Bioact. Compd. https:\/\/doi.org\/10.2174\/1573407216999200723113054 (2020).","journal-title":"Curr. Bioact. Compd."},{"key":"61362_CR134","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23336","author":"S Verma","year":"2023","unstructured":"Verma, S. et al. The combined effect of raspberry ketone with resveratrol against oxidative stress and steatohepatitis in rats: Pharmacokinetic and pharmacodynamic studies. J. Biochem. Mol. Toxicol. https:\/\/doi.org\/10.1002\/jbt.23336 (2023).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"61362_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcis.2023.07.134","author":"TH Wang","year":"2023","unstructured":"Wang, T. H. et al. Photothermal nanozymes to self-augment combination cancer therapy by dual-glutathione depletion and hyperthermia\/acidity-activated hydroxyl radical generation. J. Colloid Interface Sci. https:\/\/doi.org\/10.1016\/j.jcis.2023.07.134 (2023).","journal-title":"J. Colloid Interface Sci."},{"key":"61362_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2021.07.010","author":"E Mehmood Siddiqui","year":"2021","unstructured":"Mehmood Siddiqui, E. et al. Neuroprotective efficacy of 4-hydroxyisoleucine in experimentally induced intracerebral hemorrhage. Saudi J. Biol. Sci. https:\/\/doi.org\/10.1016\/j.sjbs.2021.07.010 (2021).","journal-title":"Saudi J. Biol. Sci."},{"key":"61362_CR137","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22526","author":"SA Reisman","year":"2020","unstructured":"Reisman, S. A., Ferguson, D. A., Lee, C. Y. I. & Proksch, J. W. Omaveloxolone and TX63682 are hepatoprotective in the STAM mouse model of nonalcoholic steatohepatitis. J. Biochem. Mol. Toxicol. https:\/\/doi.org\/10.1002\/jbt.22526 (2020).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"61362_CR138","doi-asserted-by":"publisher","DOI":"10.1177\/09603271221084276","author":"RK Yadav","year":"2022","unstructured":"Yadav, R. K. et al. Protective effects of apigenin on methylmercury-induced behavioral\/neurochemical abnormalities and neurotoxicity in rats. Hum. Exp. Toxicol. https:\/\/doi.org\/10.1177\/09603271221084276 (2022).","journal-title":"Hum. Exp. Toxicol."},{"key":"61362_CR139","doi-asserted-by":"publisher","first-page":"149251","DOI":"10.1016\/j.brainres.2024.149251","volume":"1846","author":"M Kumar","year":"2025","unstructured":"Kumar, M. et al. Therapeutic efficacy of Genistein in activation of neuronal AC\/cAMP\/CREB\/PKA and mitochondrial ETC-Complex pathways in experimental model of autism: Evidence from CSF, blood plasma and brain analysis. Brain Res. 1846, 149251. https:\/\/doi.org\/10.1016\/j.brainres.2024.149251 (2025).","journal-title":"Brain Res."},{"key":"61362_CR140","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12813","author":"A Junker","year":"2020","unstructured":"Junker, A. et al. Extensive subpial cortical demyelination is specific to multiple sclerosis. Brain Pathol. https:\/\/doi.org\/10.1111\/bpa.12813 (2020).","journal-title":"Brain Pathol."},{"key":"61362_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17122009","author":"M Di Bari","year":"2016","unstructured":"Di Bari, M. et al. Dysregulated homeostasis of acetylcholine levels in immune cells of RR-multiple sclerosis patients. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms17122009 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"61362_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8060153","author":"V Gatta","year":"2020","unstructured":"Gatta, V., Mengod, G., Reale, M. & Tata, A. M. Possible correlation between cholinergic system alterations and neuro\/inflammation in multiple sclerosis. Biomedicines https:\/\/doi.org\/10.3390\/biomedicines8060153 (2020).","journal-title":"Biomedicines"},{"key":"61362_CR143","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27740","author":"MS Moehle","year":"2019","unstructured":"Moehle, M. S. & Conn, P. J. Roles of the M4 acetylcholine receptor in the basal ganglia and the treatment of movement disorders. Mov. Disord. https:\/\/doi.org\/10.1002\/mds.27740 (2019).","journal-title":"Mov. Disord."},{"issue":"Q3","key":"61362_CR144","doi-asserted-by":"publisher","first-page":"134","DOI":"10.7224\/1537-2073.2022-030","volume":"26","author":"M Sefero\u011flu","year":"2024","unstructured":"Sefero\u011flu, M., Aksoy, M. K. & Tun\u00e7, A. Hand grip strength as a predictive tool for upper extremity functionality, balance, and quality of life in people with multiple sclerosis. Int. J. MS Care 26(Q3), 134\u2013139 (2024).","journal-title":"Int. J. MS Care"},{"key":"61362_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.01395","author":"N Val\u00e8","year":"2020","unstructured":"Val\u00e8, N. et al. Characterization of upper limb impairments at body function, activity, and participation in persons with multiple sclerosis by behavioral and EMG assessment: A cross-sectional study. Front. Neurol. https:\/\/doi.org\/10.3389\/fneur.2019.01395 (2020).","journal-title":"Front. Neurol."},{"key":"61362_CR146","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro201811808277","author":"TV Baidina","year":"2018","unstructured":"Baidina, T. V., Trushnikova, N. & Danilova, M. A. Interferon-induced depression and peripheral blood serotonin in patients with multiple sclerosis. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova https:\/\/doi.org\/10.17116\/jnevro201811808277 (2018).","journal-title":"Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova"},{"key":"61362_CR147","unstructured":"Baidina, T. V., Akintseva, Y. V., Trushnikova, T. N. A chronic fatigue syndrome and blood platelet serotonin levels in patients with multiple sclerosis. Zhurnal Nevrol i Psihiatr Im SS Korsakova. (2014)."},{"key":"61362_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2009.10.004","author":"CI Mitsonis","year":"2010","unstructured":"Mitsonis, C. I. et al. Effects of escitalopram on stress-related relapses in women with multiple sclerosis: An open-label, randomized, controlled, one-year follow-up study. Eur. Neuropsychopharmacol. https:\/\/doi.org\/10.1016\/j.euroneuro.2009.10.004 (2010).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"61362_CR149","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9320802","author":"G Al Gawwam","year":"2017","unstructured":"Al Gawwam, G. & Sharquie, I. K. Serum glutamate is a predictor for the diagnosis of multiple sclerosis. Sci. World J. https:\/\/doi.org\/10.1155\/2017\/9320802 (2017).","journal-title":"Sci. World J."},{"key":"61362_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(80)90088-X","author":"FC Westall","year":"1980","unstructured":"Westall, F. C., Hawkins, A., Ellison, G. W. & Myers, L. W. Abnormal glutamic acid metabolism in multiple sclerosis. J. Neurol. Sci. https:\/\/doi.org\/10.1016\/0022-510X(80)90088-X (1980).","journal-title":"J. Neurol. Sci."},{"key":"61362_CR151","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061817","author":"A Tisell","year":"2013","unstructured":"Tisell, A. et al. Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0061817 (2013).","journal-title":"PLoS ONE"},{"key":"61362_CR152","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-306662","author":"N Muhlert","year":"2014","unstructured":"Muhlert, N. et al. Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions. J. Neurol. Neurosurg. Psychiatry https:\/\/doi.org\/10.1136\/jnnp-2013-306662 (2014).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"61362_CR153","unstructured":"Miller, G. D. Appetite Regulation: Hormones, Peptides, and Neurotransmitters and Their Role in Obesity. American Journal of Lifestyle Medicine. (2019)."},{"key":"61362_CR154","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000979","author":"T Uher","year":"2021","unstructured":"Uher, T. et al. Evolution of brain volume loss rates in early stages of multiple sclerosis. Neurol Neuroimmunol Neuroinflamm https:\/\/doi.org\/10.1212\/NXI.0000000000000979 (2021).","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"61362_CR155","doi-asserted-by":"crossref","unstructured":"Zivadinov, R., Keenan, A. J., Oliva, R. E., Vivian, V. E. Sumeet Singh EVERSANA Brian Hutton A. Brain volume loss in relapsing multiple sclerosis: Indirect treatment comparisons of available disease-modifying therapies. BMC Neurol. (2023).","DOI":"10.21203\/rs.3.rs-3611288\/v1"},{"key":"61362_CR156","doi-asserted-by":"publisher","DOI":"10.1186\/s42466-024-00339-y","author":"C Reinhardt","year":"2024","unstructured":"Reinhardt, C. et al. Real-world analysis of brain atrophy in multiple sclerosis patients with an artificial intelligence based software tool. Neurol. Res. Pract. https:\/\/doi.org\/10.1186\/s42466-024-00339-y (2024).","journal-title":"Neurol. Res. Pract."},{"key":"61362_CR157","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09841-0","author":"C Engl","year":"2020","unstructured":"Engl, C. et al. Cognitive impairment in early MS: Contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy. J. Neurol. https:\/\/doi.org\/10.1007\/s00415-020-09841-0 (2020).","journal-title":"J. Neurol."},{"key":"61362_CR158","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10576-9","author":"S Ruggieri","year":"2021","unstructured":"Ruggieri, S. et al. A matter of atrophy: Differential impact of brain and spine damage on disability worsening in multiple sclerosis. J. Neurol. https:\/\/doi.org\/10.1007\/s00415-021-10576-9 (2021).","journal-title":"J. Neurol."},{"key":"61362_CR159","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.987293","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. DL-3-n-butylphthalide (NBP) alleviates poststroke cognitive impairment (PSCI) by suppressing neuroinflammation and oxidative stress. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.987293 (2023).","journal-title":"Front. Pharmacol."},{"key":"61362_CR160","doi-asserted-by":"crossref","unstructured":"Hajiluian, G., Karegar, S. J., Shidfar, F., Aryaeian, N., Salehi, M., Lotfi, T., et al. The effects of Ellagic acid supplementation on neurotrophic, inflammation, and oxidative stress factors, and indoleamine 2, 3-dioxygenase gene expression in multiple sclerosis patients with mild to moderate depressive symptoms: A randomized, triple-blind,. Phytomedicine. (2023).","DOI":"10.1016\/j.phymed.2023.155094"},{"key":"61362_CR161","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03496-8","author":"RAA Abo-Elsoud","year":"2024","unstructured":"Abo-Elsoud, R. A. A. et al. Pirfenidone mitigates demyelination and electrophysiological alterations in multiple sclerosis: Targeting NF-\u03baB, sirt1, and neurotrophic genes. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-024-03496-8 (2024).","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"61362_CR162","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.650708","author":"C Dang","year":"2021","unstructured":"Dang, C., Lu, Y., Chen, X. & Li, Q. Baricitinib ameliorates experimental autoimmune encephalomyelitis by modulating the Janus kinase\/signal transducer and activator of transcription signaling pathway. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.650708 (2021).","journal-title":"Front. Immunol."},{"key":"61362_CR163","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200752","author":"M Cummings","year":"2018","unstructured":"Cummings, M. et al. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0200752 (2018).","journal-title":"PLoS ONE"},{"key":"61362_CR164","doi-asserted-by":"crossref","unstructured":"Arndt, L. M., Kerkering, J., Kuehl, T., Gil, A., Friedemann, I., Sebastian, K., et al. Inflammatory Cytokines Associated with Multiple Sclerosis Directly Induce Alterations of Neuronal Cytoarchitecture in Human Neurons. pp. 145\u201359. (2023).","DOI":"10.1007\/s11481-023-10059-w"},{"key":"61362_CR165","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19701-7","author":"M Reale","year":"2018","unstructured":"Reale, M. et al. Butyrylcholinesterase and acetylcholinesterase polymorphisms in multiple sclerosis patients: Implication in peripheral inflammation. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-018-19701-7 (2018).","journal-title":"Sci. Rep."},{"key":"61362_CR166","doi-asserted-by":"crossref","unstructured":"Reale, M., Di Bari, M., Di Nicola, M., D\u2019Angelo, C., De Angelis, F., Velluto L, et al. Nicotinic receptor activation negatively modulates pro-inflammatory cytokine production in multiple sclerosis patients. Int. Immunopharmacol. (2015)","DOI":"10.1016\/j.intimp.2015.06.034"},{"key":"61362_CR167","doi-asserted-by":"publisher","DOI":"10.1159\/000356522","author":"R Reuss","year":"2014","unstructured":"Reuss, R. et al. FADD is upregulated in relapsing remitting multiple sclerosis. NeuroImmunoModulation https:\/\/doi.org\/10.1159\/000356522 (2014).","journal-title":"NeuroImmunoModulation"},{"key":"61362_CR168","doi-asserted-by":"publisher","DOI":"10.7150\/thno.26249","author":"S Herman","year":"2018","unstructured":"Herman, S. et al. Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis. Theranostics https:\/\/doi.org\/10.7150\/thno.26249 (2018).","journal-title":"Theranostics"},{"key":"61362_CR169","unstructured":"Mirzaii-Dizgah, M. H., Mirzaii-Dizgah, M. R., Mirzaii-Dizgah, I. Serum and saliva myelin basic protein as multiple sclerosis biomarker. Basic Clin. Neurosci. (2021)"},{"key":"61362_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010894","author":"C Agliardi","year":"2023","unstructured":"Agliardi, C. et al. Myelin basic protein in oligodendrocyte-derived extracellular vesicles as a diagnostic and prognostic biomarker in multiple sclerosis: A pilot study. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms24010894 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"61362_CR171","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67934-2","author":"X Ayrignac","year":"2020","unstructured":"Ayrignac, X. et al. Serum GFAP in multiple sclerosis: Correlation with disease type and MRI markers of disease severity. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-020-67934-2 (2020).","journal-title":"Sci. Rep."},{"key":"61362_CR172","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67504-6","author":"S Thebault","year":"2020","unstructured":"Thebault, S. et al. Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-020-67504-6 (2020).","journal-title":"Sci. Rep."},{"key":"61362_CR173","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00338","author":"KN Varhaug","year":"2019","unstructured":"Varhaug, K. N., Torkildsen, \u00d8., Myhr, K. M. & Vedeler, C. A. Neurofilament light chain as a biomarker in multiple sclerosis. Front. Neurol. https:\/\/doi.org\/10.3389\/fneur.2019.00338 (2019).","journal-title":"Front. Neurol."},{"key":"61362_CR174","doi-asserted-by":"publisher","DOI":"10.1186\/s41983-024-00802-2","author":"SE Fathy","year":"2024","unstructured":"Fathy, S. E., AbdAllah, A. M. & Helal, R. Y. Neutrophil\u2013lymphocyte ratio and platelet\u2013lymphocyte ratio as predictors of MS severity: A retrospective cohort study. Egypt. J. Neurol. Psychiatry Neurosurg. https:\/\/doi.org\/10.1186\/s41983-024-00802-2 (2024).","journal-title":"Egypt. J. Neurol. Psychiatry Neurosurg."},{"key":"61362_CR175","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01942-8","author":"T Akaishi","year":"2021","unstructured":"Akaishi, T. et al. White blood cell count profiles in multiple sclerosis during attacks before the initiation of acute and chronic treatments. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-021-01942-8 (2021).","journal-title":"Sci. Rep."},{"key":"61362_CR176","doi-asserted-by":"publisher","DOI":"10.1159\/000363515","author":"P Wang","year":"2014","unstructured":"Wang, P., Xie, K., Wang, C. & Bi, J. Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis. Eur. Neurol. https:\/\/doi.org\/10.1159\/000363515 (2014).","journal-title":"Eur. Neurol."},{"key":"61362_CR177","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-5-27","author":"WA Sheremata","year":"2008","unstructured":"Sheremata, W. A. et al. Evidence of platelet activation in multiple sclerosis. J. Neuroinflammation https:\/\/doi.org\/10.1186\/1742-2094-5-27 (2008).","journal-title":"J. Neuroinflammation"},{"key":"61362_CR178","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04928-y","author":"D Obradovic","year":"2021","unstructured":"Obradovic, D., Andjelic, T., Ninkovic, M., Dejanovic, B. & Kotur-Stevuljevic, J. Superoxide dismutase (SOD), advanced oxidation protein products (AOPP), and disease-modifying treatment are related to better relapse recovery after corticosteroid treatment in multiple sclerosis. Neurol. Sci. https:\/\/doi.org\/10.1007\/s10072-020-04928-y (2021).","journal-title":"Neurol. Sci."},{"key":"61362_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2022.10.009","author":"TB Willingham","year":"2023","unstructured":"Willingham, T. B., McCully, K. & Backus, D. Skeletal muscle dysfunction in people with multiple sclerosis: A physiological target for improving physical function and mobility. Arch. Phys. Med. Rehabil. https:\/\/doi.org\/10.1016\/j.apmr.2022.10.009 (2023).","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"61362_CR180","doi-asserted-by":"publisher","first-page":"106190","DOI":"10.1016\/j.msard.2024.106190","volume":"93","author":"T Gaemelke","year":"2025","unstructured":"Gaemelke, T., Pedersen, I. S., Dalgas, U. & Hvid, L. G. Sarcopenia in older people with multiple sclerosis: A cross-sectional study. Mult. Scler. Relat. Disord. 93, 106190. https:\/\/doi.org\/10.1016\/j.msard.2024.106190 (2025).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"61362_CR181","doi-asserted-by":"crossref","unstructured":"Asikin, M. D., Widajanti, N., Firdausi, H., Widodo. Myostatin and Sarcopenia in Elderly Among Haemodyalisis Patient. J. Nat. Sci. Biol. Med. (2021)","DOI":"10.4103\/jnsbm.JNSBM_12_3_4"},{"key":"61362_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2009.04.018","author":"KP Elishkevitz","year":"2009","unstructured":"Elishkevitz, K. P., Nussinovitch, U. & Nussinovitch, M. Lactic dehydrogenase isoenzymes in adolescents with multiple sclerosis. Pediatr. Neurol. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2009.04.018 (2009).","journal-title":"Pediatr. Neurol."},{"key":"61362_CR183","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880170703","author":"H Kawai","year":"1994","unstructured":"Kawai, H. et al. Expression of myoglobin gene in skeletal muscle of patients with neuromuscular diseases. Muscle Nerve https:\/\/doi.org\/10.1002\/mus.880170703 (1994).","journal-title":"Muscle Nerve"},{"key":"61362_CR184","doi-asserted-by":"publisher","DOI":"10.1159\/000368551","author":"ON Nadhem","year":"2014","unstructured":"Nadhem, O. N., Al Janabi, M., Omer, A. R. & Wan, B. Autoimmune hepatitis with multiple sclerosis and graves disease: Coincidence or association. Case Rep. Gastroenterol. https:\/\/doi.org\/10.1159\/000368551 (2014).","journal-title":"Case Rep. Gastroenterol."},{"key":"61362_CR185","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000238515.27055.62","author":"H Tremlett","year":"2006","unstructured":"Tremlett, H. et al. Liver test abnormalities in multiple sclerosis: Findings from placebo-treated patients. Neurology https:\/\/doi.org\/10.1212\/01.wnl.0000238515.27055.62 (2006).","journal-title":"Neurology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61362-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61362-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61362-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:02:00Z","timestamp":1791500520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61362-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":185,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["61362"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-61362-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors approve of submitting the publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31567"}}